XML 69 R58.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent Event (Details)
 3 Months Ended
Nov. 03, 2023
USD ($)
payment
Oct. 23, 2023
shares
Jun. 30, 2022
shares
Subsequent Event [Line Items]      
Exercise of warrants (in shares) | shares     253,000
Subsequent Event | Clearside Biomedical, Inc.      
Subsequent Event [Line Items]      
Upfront payment $ 5,000,000    
Number of milestone payments | payment 3    
Number of royalties tiers | payment 3    
Subsequent Event | Clearside Biomedical, Inc. | Maximum      
Subsequent Event [Line Items]      
Potential milestone payment $ 30,000,000    
Potential payment if milestone reached 47,500,000    
Subsequent Event | Clearside Biomedical, Inc. | Annual Net Sales Of $2 Million      
Subsequent Event [Line Items]      
Annual global net sales 2,000,000,000    
Subsequent Event | Clearside Biomedical, Inc. | Annual Net Sales Greater Than $1.5 Million      
Subsequent Event [Line Items]      
Annual global net sales $ 1,500,000,000    
Subsequent Event | Common Stock      
Subsequent Event [Line Items]      
Exercise of warrants (in shares) | shares   14,997,000  
Subsequent Event | Warrants to purchase common stock      
Subsequent Event [Line Items]      
Warrants outstanding (in shares) | shares   0